Cabaletta Bio CABA
NASDAQ CABA
$1.89 -0.03 (-1.56%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cabaletta Bio (CABA) Non Operating Interest Expenses (2024 - 2026)

Updated

Cabaletta Bio's Non Operating Interest Expenses came in at $517,000 for Q2 2026, down 9.5% from $571,000 a year earlier.

Analysis

Cabaletta Bio (CABA) Non Operating Interest Expenses (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cabaletta Bio reported Non Operating Interest Expenses of $2.23 million, up 38.1% year-over-year; for FY2025, it came in at $2 million, up 167.9% from FY2024.

  • Going back by year, Non Operating Interest Expenses was $748,000 in FY2024.
  • The Q2 2026 figure represents the lowest quarterly Non Operating Interest Expenses since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cabaletta Bio 325.53 Mn 325.53 Mn - 517,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 517,000.00
Dec 31, 2025 555,000.00
Sep 30, 2025 584,000.00
Jun 30, 2025 571,000.00
Mar 31, 2025 294,000.00
Dec 31, 2024 748,000.00
API Access

Cabaletta Bio Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CABA&period=max&api_key=YOUR_API_KEY